PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMI Publishing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

20/20 Pharma Announces Live Expert Discussion on Patient Recruitment - A look at patient recruitment in this executive interview with Pfizer’s Craig Lipset and Dr Rick Malcolm of Acurian, a leading company in the field of patient recruitment - 2020Pharma.com
20/20 Pharma Announces Live Expert Discussion on Patient Recruitment

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/07/05 - A look at patient recruitment in this executive interview with Pfizer’s Craig Lipset and Dr Rick Malcolm of Acurian, a leading company in the field of patient recruitment - 2020Pharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Industry experts go head to head in 20/20 Pharma’s ‘Advancing patient recruitment’ podcast discussion. Patient recruitment is an essential element to clinical trials and this discussion gives audiences a look at patient recruitment today.

The podcast is moderated by Craig Lipset, Pfizer’s Head of Clinical Innovation, Development Operations, Worldwide Research & Development, who is joined by Dr Rick Malcolm, Chief Executive Officer of Acurian.

The podcast is an insightful analysis of patient recruitment and includes comments on:

- The challenges patient recruitment brings to clinical trials;
- Myths and misconceptions of patient recruitment;
- Opportunities in electronic health data;
- E-patients fitting into clinical trials;
- Budgeting for patient recruitment;
- Forecasting the future of clinical trials.

In the podcast Rick Malcolm said: “Over the years we have sent letters and contacted millions of people about participation in clinical trials and as you know it is highly regulated.

“We have hundreds of thousands of people in the United States that respond to these invitations that have an interest in participating in clinical trials.”

He also commented: “On a regular basis, an increasing number of physicians and healthcare systems are doing more and more with electronic health records, which certainly holds out the possibility to be even more targeted in who you reach out to.”

For more information and topical pharmaceutical related podcasts visit the webstie.

About 20/20 Pharma
20/20 Pharma (2020pharma.com) is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.
Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry’s top issues and the solutions that top-tier vendors can provide.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMI Publishing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


20/20 Pharma Announces Live Expert Discussion on Patient Recruitment

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Pinar Gencturk - IMIpublishing.com 
+44 207 148 5152 pgencturk[.]imipublishing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMI Publishing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMI Publishing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)